Daily Archives: April 21, 2022
RCT: Calorie restriction combined with time-restricted eating (eating from 8:00 am to 4:00 pm) did not significantly decrease weight loss compared to calorie restriction alone at 12 months (net difference, −1.8 kg; 95% CI, −4.0 to 0.4; P=0.11).
21 Apr, 2022 | 10:31h | UTCCalorie Restriction with or without Time-Restricted Eating in Weight Loss- New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Time-Restricted Eating No Better Than Cutting Calories for Obesity – HealthDay
Commentary on Twitter
As compared with calorie restriction, time-restricted eating does not produce additional benefits with regard to reduction of body weight, body fat, and metabolic risk factors. https://t.co/Ygx4zbC6QP pic.twitter.com/TGE5Pva3yS
— NEJM (@NEJM) April 20, 2022
RCT: Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for prevention of Covid-19.
21 Apr, 2022 | 10:29h | UTC
Commentary on Twitter
AZD7442 (tixagevimab/cilgavimab) found to have about 76% efficacy in preventing symptomatic Covid-19 infection. https://t.co/8tmvz3xI4I pic.twitter.com/fOegZjBRA6
— NEJM (@NEJM) April 20, 2022
[News release – not published yet] New guidelines from WHO recommend a simpler, safer treatment for cryptococcal disease in people living with HIV.
21 Apr, 2022 | 10:28h | UTCRelated Study: Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis – New England Journal of Medicine (link to abstract – $ for full-text)
Cohort study: COVID-19 infection granted patients strong and long-lasting protection from reinfection.
21 Apr, 2022 | 10:20h | UTCNews Release: COVID-19 infection granted patients strong and long-lasting protection from reinfection – Providence Health & Services
Original Study: Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19 – JAMA Network Open
Commentary: COVID-19 infection may offer similar immunity as vaccination – CIDRAP
Commentary on Twitter
This US cohort study found that unvaccinated individuals with prior symptomatic #COVID19 had 85% lower risk against recurrent COVID-19 compared to unvaccinated individuals without prior infection, for up to 9 months, through November, 2021. https://t.co/1qHCFmGqXG
— JAMA Network Open (@JAMANetworkOpen) April 20, 2022
SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents.
21 Apr, 2022 | 10:23h | UTCEditorial: Communicating the Benefits of Vaccination in Light of Potential Risks
SCAI Position Statement on best practices for percutaneous axillary arterial access and training.
21 Apr, 2022 | 10:02h | UTCCommentary: Percutaneous Axillary Access: SCAI Calls for Best Practices – TCTMD
Commentary on Twitter
@SCAI releases new document on "Best Practices on Percutaneous Transaxillary Arterial Access and Training."https://t.co/TFsK84nFMe pic.twitter.com/7jNSeuSdEF
— MyJSCAI (@MyJSCAI) April 19, 2022
Vitamin D supplements in pregnancy: what’s the latest evidence?
21 Apr, 2022 | 09:58h | UTCVitamin D supplements in pregnancy: what’s the latest evidence? – Evidently Cochrane Blog
Original Study: Vitamin D supplementation for women during pregnancy – Cochrane Library
British Guideline for the treatment of chronic lymphocytic leukemia.
21 Apr, 2022 | 10:00h | UTCGuideline for the treatment of chronic lymphocytic leukaemia – British Journal of Haematology
RCT: Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.
21 Apr, 2022 | 09:56h | UTCIvosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Ivosidenib and azacitidine showed clinical benefit as compared with placebo and azacitidine in patients with newly diagnosed IDH1-mutated AML, a difficult-to-treat population. https://t.co/6K6mWJdd2V pic.twitter.com/qOwOvHcV4j
— NEJM (@NEJM) April 20, 2022
Retinal age gap as a predictive biomarker of future risk of Parkinson’s disease.
21 Apr, 2022 | 09:54h | UTCRetinal age gap as a predictive biomarker of future risk of Parkinson’s disease – Age and Ageing
Related: Retinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)